NCT01622595

Brief Summary

OBSERVATIONAL STUDY OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

June 15, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 19, 2012

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

October 27, 2015

Status Verified

October 1, 2015

Enrollment Period

6.1 years

First QC Date

June 15, 2012

Last Update Submit

October 26, 2015

Conditions

AspergillosisCandidemiaC. Difficile

Keywords

AspergillosisCandidemiaCandidiasisC. Difficilecytomegalovirusrespiratory syncytial virus (RSV)InfluenzaCONS

Outcome Measures

Primary Outcomes (1)

  • To study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients

    To study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients

    3 years

Secondary Outcomes (1)

  • incidence

    3 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

cancer patients with Infections

You may qualify if:

  • cancer patients with Infections

You may not qualify if:

  • No Infections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205, United States

Location

MeSH Terms

Conditions

AspergillosisCandidemiaCandidiasisInfluenza, Human

Condition Hierarchy (Ancestors)

MycosesBacterial Infections and MycosesInfectionsCandidiasis, InvasiveInvasive Fungal InfectionsFungemiaSepsisSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsRespiratory Tract InfectionsOrthomyxoviridae InfectionsRNA Virus InfectionsVirus DiseasesRespiratory Tract Diseases

Study Officials

  • Senu Apewokin, MD

    UAMS

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2012

First Posted

June 19, 2012

Study Start

November 1, 2009

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

October 27, 2015

Record last verified: 2015-10

Locations

US(1)